Tukysa 150 mg, Filmtabletten - 84 Swissmedic Key 67798002 Registration Holder Pfizer AG Name Tukysa 150 mg, Filmtabletten Date of registration 07.05.2020 Introduction of Sequence 07.05.2020 ATC-Classification Tucatinib (L01EH03) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size 84 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680677980022 Medication Code Synthetika Pharmacode Disponibility
Composition tucatinibum 150 mg, copovidonum, crospovidonum, natrii chloridum, kalii chloridum, natrii hydrogenocarbonas, silica colloidalis anhydrica, cellulosum microcristallinum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 27.65 mg, kalium 30.29 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Tucatinibum 150 mg
Inactive agents Dose additional_information (Flavum) Cellulosum Microcristallinum Copovidonum Crospovidonum E 171 color. E 172 color. Potassium Chloride Potassium 30.29 mg Macrogol 4000 Magnesii Stearas Sodium Chloride Sodium Hydrogen Carbonate Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum
Source Data was imported : 04.10.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :